Sitagliptin: what it does and what to watch
Also known as: Sitagliptin phosphate · DPP-4 inhibitor (oral diabetes medicine) · Updated 2026-08-19 · Educational — not medical advice
In plain language: It blocks an enzyme called DPP-4 that normally breaks down incretin hormones released after eating. With that enzyme blocked, incretins last longer and help the pancreas release more insulin when blood sugar is high while also reducing glucagon, a hormone that raises blood sugar. Because this pathway is tied to current blood sugar levels, it carries a comparatively low risk of causing blood sugar to drop too low on its own.
What it's used for
- Type 2 diabetes blood sugar management
- Often added alongside metformin for extra control without weight gain
Common side effects
- Headache
- Upper respiratory symptoms such as a stuffy nose or sore throat
- Stomach upset
- Mild joint discomfort
Get medical help if…
Severe, persistent abdominal pain, which can signal pancreas inflammation (pancreatitis)
Severe joint pain that develops after starting the medicine
Signs of an allergic reaction, including facial swelling or difficulty breathing
Rare, severe skin reactions
Lab values it can move
Few guides tell you this part: medicines show up in blood work. If you take Sitagliptin and a value below looks off on your report, this may be part of the story — never stop a medicine without your doctor.
Sitagliptin lowers fasting glucose modestly by boosting the body's own insulin response after eating.
Fasting GlucoseWith regular use, HbA1c typically falls as average blood sugar control improves, though usually less dramatically than with some other diabetes medicine classes.
HbA1cGood to know
- Severe abdominal pain should be reported promptly, as it can be an early sign of pancreatitis
- Carries a low risk of low blood sugar on its own, but the risk rises when combined with a sulfonylurea or insulin
- Kidney function affects how the medicine is cleared, so dosing is adjusted for reduced kidney function
- New or worsening joint pain has been reported and is worth mentioning to a doctor
- Regular blood sugar monitoring still matters even though this class rarely causes lows by itself
Questions people ask
Why does sitagliptin have a lower risk of low blood sugar than sulfonylureas?
Sitagliptin works by extending the life of hormones that only ramp up insulin release when blood sugar is already elevated after a meal. Once blood sugar returns to a normal range, that extra insulin signal fades on its own, unlike sulfonylureas, which can keep pushing insulin release somewhat regardless of the current glucose level. This built-in feedback is why sitagliptin alone rarely causes blood sugar to drop too low.
What abdominal symptoms should prompt concern on sitagliptin?
Severe, persistent pain in the upper abdomen, sometimes spreading to the back, along with nausea or vomiting, can be an early sign of pancreas inflammation, a rare but recognized risk with this drug class. This is different from the milder, short-lived stomach upset some people notice when starting the medicine, and severe or persistent pain warrants prompt medical evaluation rather than waiting it out.
Taking Sitagliptin? See what your blood work says.
Upload your lab report — every value checked and explained. Free — no account needed.